Chapter 107 Half-year financial report & income review! (Please subscribe)
As usual, Zhang Yang withdrew the drug reward before exiting the simulator.
However,
Zhang Yang is unable to change the final outcome of this time, just like the final text summary of the simulator,
The key to kidney disease is early detection and early treatment. Once it reaches the stage of uremia, no one can reverse it.
Fortunately, although this reward is only a temporary emergency substitute for dialysis, it can still provide a better quality of life for some dialysis patients.
In the following days, Zhang Yang began to research this "Kidney Clear Dialysis Substitute Injection".
He was still prepared to thoroughly understand the ingredients of this drug as before. and mechanism of action, and then transferred to the R&D center for secondary research and development, and finally achieve complete effects on the market.
Although this is troublesome, after a set of procedures, the drug can be regarded as having gone through a complete research and development process, which is much more reasonable than taking it out directly.
Moreover, he has noticed that not only his understanding of drugs has greatly improved during the learning process, but also the R&D members of the entire R&D center team have also rapidly improved their ability to participate in the development of these excellent semi-finished drugs. .
In this case, why not do it.
While Zhang Yang was fully immersed in the learning process of "Shenduqing Injection", on July 10, Ren Xiaomin walked into the office with a thick document and a smile on his face.
“Zhang Yang, guess what I’m holding in my hand?”
Zhang Yang put away the animal experiment data on the table and shook his head with a smile.
“Brother Ren, I can’t guess, but the look on your face must be a good thing.”
"Haha, yes, it's good news!"
Ren Xiaomin laughed.
As Qingshan Pharmaceutical grows stronger, the division of labor between him and Zhang Yang becomes clearer.
Zhang Yang is mainly responsible for drug research and development, that is, the R&D center, as well as major company decisions, such as signing an agency contract with Novartis.
As for him, he is mainly responsible for the company's internal management, coordination of resources, human recruitment and other internal matters.
Zhang Yang is naturally very relieved about Ren Xiaomin. Ren's more than ten years of experience in Beifeng Pharmaceutical is enough to show that he has an upright character and does not engage in intrigues. If he manages the company, there will be no trouble within the company and it will save him a lot of energy.
“Okay, I won’t play charades anymore. Major hospitals and agents have settled their drug payments for the first half of this year, and the medical insurance has added an additional payment for ‘Acofenprofovir’. Orders,
Look how much money we have made in the past six months!”
Oh?
Zhang Yang was also quite curious and hurriedly took the half-year financial report from Ren Xiaomin. After taking a few glances, he was immediately surprised.
At present, Qingshan Pharmaceutical has a total of three drugs for external sales.
The first product is "Avatrombopag Qingshan".
With the comprehensive promotion and application of "Qingshan Ava" in Huaxia Hospital in the past two years, "Qingshan Ava" has become the main first-line treatment drug for the treatment of "thrombocytopenia" in China!
It is widely used in hematology, hepatology and oncology departments.
In the first half of the year alone, the shipment volume of "Qingshan Avatropopa" exceeded 1 million boxes, with sales reaching 480 million yuan, successfully taking over the previous market share of AkaRx.
Of course,
Since the price of first-generation platelet treatment drugs such as "Eltrombopag" has been reduced, it is much cheaper than "Avatar Qingshan", many patients still choose to continue taking "Eltrombopag".
There are also some patients who are afraid to eat the best "Qingshan Ava" not because they cannot afford it, but in the end, if drug resistance develops, there will be no alternative.
But no matter what, "Qingshan Ava" has become the best drug for treating "thrombocytopenia", firmly occupying the largest share of the top market.
AkaRx Company has completely changed its sales strategy as Tsingshan Pharmaceutical quickly entered major tertiary hospitals. They no longer pursue a price war with Tsingshan Pharmaceutical, but instead turn to private hospitals in China to "import Harvest the country's middle class in the name of "drug".
Zhang Yang is very satisfied with the sales situation. After all, "Qingshan Ava" is a drug that needs to be taken for a long time, and as time goes by, the market penetration rate of "Qingshan Ava" will increase in the next ten years.
He looked at the second drug - "ITG human myelopoietin".
In the first half of the year, domestic sales of "ITG injections" reached 1 million, each priced at 2,800 yuan, and the total domestic sales amount reached 2.8 billion yuan!
Based on the assumption that one patient needs 10 injections, 100,000 patients were cured last year alone.
There are 1.5 million patients with aplastic anemia in China. Perhaps because the symptoms are not severe, or perhaps because there is not enough treatment money at the moment, most of the patients with aplastic anemia have not yet taken action.
But Zhang Yang is already very satisfied with this data.
It is foreseeable that at least in the next five years, more patients with aplastic anemia will receive treatment one after another, and "ITG human myeloidin" can at least bring sales of over 10 billion to Qingshan Pharmaceutical.
In addition to domestic sales data, sales to Southeast Asia, represented by Fuxing Pharmaceutical, have also reached 100,000.
Treating an aplastic patient with 10 pills in just a short period of time Ten thousand people have received treatment in Southeast Asia in half a year!
Ten thousand people sounds like a small amount, but the final amount made Zhang Yang chuckle!
100,000 pieces, each priced at US$3,000, with a sales volume of US$300 million!
Converted into RMB, up to 2.1 billion!
"Brother Ren, you'd better go to sea. The exchange rate for money outside is so cool!" Zhang Yang couldn't help but sigh.
“Yes.”
Ren Xiaomin also smiled and nodded:
"Moreover, because the country now encourages pharmaceutical exports, all pharmaceutical exports have zero tariffs, which means that our profits are pure profits and we do not need to pay additional tariffs."
Zhang Yang snorted. Over the years, In order to promote pharmaceutical companies to go overseas, the state has indeed given many preferential policies. Just zero tariffs can save countless pharmaceutical companies a lot of tax.
He continued to look down.
The last drug of Tsingshan Pharmaceutical is "Acofenprofovir".
Although Tsingshan Pharmaceutical has also put this drug on the shelves of JD Pharmacy and major pharmacies, the main purchase volume still comes from the special medical insurance fund.
The last time "Ekofuvir" was released, the medical insurance fund purchased 10 million bottles for a total of 5 million hepatitis B patients.
This quantity is obviously not enough.
So, this time there were 10 million more visitors, 20 million bottles were purchased, each bottle cost 500 yuan, and the total sales amount was as high as -
10 billion.
I feel a little embarrassed when I see this amazing number being publicized.
However, this embarrassment only lasted for a few seconds, because he also knew that as hepatitis B patients were cured one after another, this drug would definitely not have such huge sales in the future.
He has also thought about taking this drug overseas. After all, there are still about 300 million hepatitis B patients in the world.
But except for the 120 million domestic ones, the others are basically in India, Brazil, Egypt, Cambodia...
Especially India.
Zhang Yang couldn't help but shudder, don't think too much, he would be thankful if India didn't come to challenge him...
While thinking about it, Zhang Yang continued to look.
The remaining financial reports are a series of daily expenses such as R&D expenses, production costs, operating expenses, etc.
These expenditures are so public in front of the sales amount of more than 10 billion that there is no interest in staying for one more second.
Finally, he saw the most critical column in the financial report, the company's total cash -
12.25 billion.
Zhang Yang was stunned, and his eyes seemed to be stagnant at this moment. He slowly raised his head:
“So Brother Ren, you want to tell me that our company’s available funds now are 12.25 billion?”
Ren Xiaomin He nodded excitedly and a little awkwardly.
To be honest, neither he nor Zhang Yang have ever managed so much money.
The last time the special fund for medical insurance paid in the first 5 billion, I didn’t realize it because the money was immediately transferred out to pay for production and OEM costs, and there was not much money left in the account.
This time, after the purchase order of 10 billion "Ekofuvir" was issued, the bank balance of Qingshan Pharmaceutical was completely filled.
It also allowed the two of them to see for the first time what it means to be wealthy.
After a while, Zhang Yang rubbed his temples and couldn't help but sigh:
"Brother Ren, let me slow down..."
"You said so much money, we Do something good?”
Ren Xiaomin was obviously very excited:
“I thought about it when I came here. I suggested that we buy a piece of land and build our industrial park first.”
“Buy land?”
Zhang Yang thought quickly. After the vast majority of pharmaceutical companies in the industry develop a star drug, most of them will buy land to build their own parks, or expand factories and production.
At present, Zhang Yang has no idea of establishing his own production base. After all, the cooperation with Hehua Pharmaceutical is pretty good.
Once you start to build your own production base, not only a lot of investment is required, but also reliable people must be in charge.
Now he and Ren Xiaomin don't have enough energy to take care of this matter, so they are not so anxious about establishing a production base.
He shook his head.
“I don’t feel too anxious about buying land. We are a research and development-oriented pharmaceutical company, and the area we occupy is not actually large.”
"However, the factory area where we are located is still rented, so we can buy it."
"After all, we are a tens of billions company. If we even rent the headquarters, others will be afraid if we say it. I want to laugh my head off.”
Although Ren Xiaomin was a little surprised, Zhang Yang’s last sentence also made him laugh.
After a moment, he nodded and said:
"It's okay to buy this land. Last time I talked with their boss, it was about 20 million, and the price is very reasonable."
"However, there are residential buildings around here. If we want to expand the factory area in the future, it will be more troublesome."
Zhang Yang paused for a moment, then shook his head:
"It's okay, we'll talk about it then. . ”
“The most important thing is that it is on the edge of the second ring road. It is very close to the city and out of the city. It is also very convenient for everyone to go to work.”
“If we move to the industrial park outside the third ring road. , it’s not convenient for everyone to go to work.”
"Okay."
Having said this, Ren Xiaomin said no more.
At this moment, Zhang Yang continued:
“Brother Ren, what do you think about taking this opportunity to increase everyone’s welfare benefits?”
“For example Pension insurance and provident fund”
Ren Xiaomin didn't expect that Zhang Yang, as the boss, would take the initiative to mention this matter. He glanced at Zhang Yang with relief and said:
"I think it's okay."
"At present, although our company's pension insurance is compared with provident fund, Other pharmaceutical companies are not the lowest, but they are not high either. If I remember correctly, they should be the lowest. The second level.”
“Increasing some benefits can indeed increase everyone’s collective sense of honor for the company.”
Zhang Yang was also a low-level drug researcher at Beifeng Pharmaceutical. Of course we know how the lower-level employees feel. Don’t we all go to work just to make more money?
Soon Zhang Yang called Qian Tu, the financial director in charge of the matter.
Briefly explaining the situation, Lao Qian replied:
"Mr. Zhang, currently domestic employee social security is divided into four levels, namely 40%, 60%, 80% and 100%."
“The higher the payment level, the more the company pays each month The higher the cost, of course the higher the pension insurance that employees can get after retirement. "
"Now our ordinary employees' social security is the second to last level, which is 60%," said the project leader of the Drug Research Center. It’s 80%. How do you think it should be adjusted?”
After thinking for a while, Zhang Yang ordered:
"For all ordinary employees to pay 80% of the social security premium, the project team leader of the research center pays 100%. After the adjustment, employees are not allowed to pay the extra portion. Yes, the extra expenses will be borne by the company.”
"Also, the provident fund contribution rate is 9% for ordinary employees, and it is increased to 12% for the person in charge. It is still the same. All extra expenses will be paid by the company."
Qian Tu nodded repeatedly. As the financial director, Of course he knows that the company currently has 12.25 billion lying on its books.
12.25 billion...
However, despite this, he still admired Zhang Yang very much in his heart.
There are many companies that can make money, but there are very few companies that can immediately improve their employees’ benefits after making money.
Many companies would rather make charitable donations than improve employee benefits. At the same time, they also expect employees to work overtime, which is simply putting the cart before the horse.
"Mr. Zhang, I will make arrangements now."
"Okay."
Qian Tu left, and only Zhang Yang and Ren Xiaomin were left in the office.
After chatting for a while, the two of them focused on the large amount of money again.
This time it was Ren Xiaomin who suggested:
"Zhang Yang, I think our product line is now approaching stability. After the 'ITG Generator' is successfully launched in the UK, we will continue to sell it every six months. With a large amount of income, I think it is better to put this money away In the account, it is better to make some BD investments.”
“In recent years, whether it is Hengrui or foreign companies like Pfizer and Novartis, they have been constantly increasing the number and amount of their BD transactions. This may be the way. The direction of future pharmaceutical research and development”
BD transactions are the acquisition of drug patents from other small pharmaceutical companies that have achieved certain results but have not yet been completed.
This time Zhang Yang did not express his position directly. After hesitating for a while, he shook his head slightly:
“Brother Ren, BD investment not only requires strong financial expertise, but also requires knowledge of biopharmaceuticals. We don’t have this kind of talent at the moment, and it’s hard to find it.”
“I have another plan.”
Oh?
Ren Xiaomin's eyes narrowed and he waited attentively for Zhang Yang to continue.
Zhang Yang did not beat around the bush and said directly:
"I plan to continue to promote the research and development of blood disease drugs based on our existing drugs."
"With the existing drugs On the basis of medicine? You mean 'Aoyama Ava'?"
"That's right!"
Zhang Yang nodded:
"Before, our R&D team had few people and insufficient R&D capabilities. I didn't have enough energy on my own, so I didn't promote this matter."
"Now after two or three years, With the recruitment and polishing, our drug research and development center has begun to take shape, and now the funds have become abundant, so I want to develop more drugs based on our current drugs.”
"Our 'Qingshan Avatrombopag Tablets' is a second-generation platelet-generating agent, but it will never be the last generation. There will definitely be a third and fourth generation in the future, and we can continue to upgrade."
"In addition, 'ITG human myelopoietin' can cure aplastic anemia. Based on it, we can see whether it can cure leukemia or blood diseases such as Henoch-Schonlein purpura."
"So, my next idea is to invest money in this and make the best use of existing drugs to try to develop more drugs."
Ren Xiaomin nodded heavily, he completely agreed with Zhang Yang's statement idea.
Suddenly, he thought of the patients on the Internet who had left messages on Qingshan Pharmaceutical’s Weibo.
In fact, since Tsingshan Pharmaceutical developed “ITG human myelopoietin” that can cure aplastic anemia, many leukemia patients have left messages on Tsingshan Pharmaceutical’s Weibo,
I hope that Tsingshan Pharmaceutical can start research on leukemia drugs, and also hope that Tsingshan Pharmaceutical can develop a drug to cure leukemia, so that they can get rid of the disease as soon as possible.
If this news spreads, those leukemia patients will probably cheer.
"Zhang Yang, I agree with your idea."
"We can put the BD deal on hold first and conduct research and development around our existing drugs first, so the success rate should be higher. !”
Zhang Yang breathed out and did not continue chatting on this topic.
Suddenly, he looked up at Ren Xiaomin.
"By the way, what's going on with Novartis in the United States?"
"Has the first clinical phase of our 'hepatocyte regeneration activating agent' started?"
......
PS: Thank you to the annual ring empire for the 10,000 coin reward. Thank you. There will be more updates today.
(End of this chapter)